Dana-Farber Cancer Inst

27 biology research labs · Boston, United States. Click a lab to read or write an anonymous review.

• Agudo Cantero Labno reviews yet
  NIH R01: Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment…
• Aguirre Labno reviews yet
  NIH R01: Mechanisms of response and resistance to KRAS inhibition in pancreatic cancer
• Armstrong Labno reviews yet
  NIH R01: Defining epigenetic mechanisms in NPM1c mutant leukemia
• Arthanari Labno reviews yet
  NIH R01: NMR Fingerprinting: Leveraging optimal control pulse design, tailored isotope labeling, and machine learning…
• Bao Labno reviews yet
  NIH R01: Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial
• Barbie Labno reviews yet
  NIH R01: Targeting the cytokine circuitry of KRAS-driven lung cancer
• Berbeco Labno reviews yet
  NIH R01: Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy
• Bergman Labno reviews yet
  NIH R01: Mapping the epigenetic dynamics of prostate cancer progression: integrating liquid biopsies and single-cell…
• Beroukhim Labno reviews yet
  NIH R01: Evolution of gliomas during treatment and resistance
• Brown Labno reviews yet
  NIH R01: Genetic Predisposition to Chronic Lymphocytic Leukemia (CLL)
• Burns Labno reviews yet
  NIH R01: Consequences of retrotransposition on genome integrity
• Burns Labno reviews yet
  NONE
  NIH R01: Characterizing the LINE-1 Retrotransposition-Replication Conflict
• Cancelas Labno reviews yet
  NIH R01: Mitochondria mediated intercellular metabolic coupling in bone marrow regeneration
• Cantor Labno reviews yet
  NIH R01: Contribution of a novel OPN-producing CD11c+ microglial subset to AD
• Carrasco Labno reviews yet
  NIH R01: Development of microRNA (miR)-based cell-targeted polymeric nanoparticles for myeloma therapy
• Chouchani Labno reviews yet
  NIH R01: Defining the landscape and mechanisms of protein redox regulation during aging
• Choueiri Labno reviews yet
  NIH R01: Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinoma
• Chowdhury Labno reviews yet
  NIH R01: Elucidating the molecular mechanism and physiological relevance of TIRR mediated inhibition of p53
• D'andrea Labno reviews yet
  NIH R01: Molecular Pathogenesis of Fanconi Anemia
• Danial Labno reviews yet
  NIH R01: Metabolic crosstalks in regulation of beta-cell stress response and adaptation
• Davids Labno reviews yet
  NIH R01: Optimizing novel agent combination therapy for previously untreated, high risk chronic lymphocytic leukemia
• Dougan Labno reviews yet
  NIH R01: CDK4/6 inhibition during CD8 T cell priming potentiates memory formation in mice and humans
• Eck Labno reviews yet
  NIH R01: Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M
• Engelman Labno reviews yet
  NIH R01: HIV-1 Preintegration Trafficking and Nuclear Localization
• Enzinger Labno reviews yet
  NIH R01: A multi-level examination of the influences of racism on cancer pain equity
• Fischer Labno reviews yet
  NIH R01: The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase
• Freedman Labno reviews yet
  NIH R01: Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies